Hybridization-based fluorescence assay
The invention provides a method for detecting the presence or absence of an oligonucleotide in a sample. In the method according to the invention, a sample is obtained that may contain a target oligonucleotide. An oligonucleotide that is complementary to the target oligonucleotide and a fluorophore are added to the sample to form a mixture. The mixture is then incubated under hybridization conditions to allow binding of the complementary oligonucleotide to the target oligonucleotide to form a duplex. The fluorophore binds to the duplex; and fluorescence is then detected by standard procedures. The detection of fluorescence is indicative of the presence of the target oligonucleotide in the sample.
1 . A method for detecting the presence or absence of an oligonucleotide in a sample, comprising the steps of:
a) obtaining a sample;
b) adding to the sample an oligonucleotide that is complementary to a target oligonucleotide to form a mixture;
c) adding a fluorophore to the mixture;
d) incubating the mixture under conditions to allow binding of the complementary oligonucleotide to the target oligonucleotide to form a duplex;
e) binding of the fluorophore to the duplex; and
f) detecting fluorescence being indicative of the presence of the target oligonucleotide in the sample.
2 . The method of claim 1 , wherein the sample is contained in a microtiter plate.
3 . The method of claim 1 , where the presence or absence or an oligonucleotide in two or more samples is detected.
4 . The method of claim 3 , wherein the two or more samples are contained in different wells of a multiwell microtiter plate.
5 . The method of claim 1 , wherein the complementary oligonucleotide is conjugated to the fluorophore prior to adding to the sample.
6 . A method for determining the concentration of an oligonucleotide present in a sample, comprising the steps of:
a) Obtaining a sample;
b) Adding to the sample an oligonucleotide that is complementary to a target oligonucleotide to form a mixture;
c) Adding a fluorophore to the mixture;
d) Treating the mixture under conditions to allow binding of the complementary oligonucleotide to the target oligonucleotide to form a duplex;
e) Binding of the fluorophore to the duplex;
f) Detecting fluorescence being indicative of the presence of the target oligonucleotide in the sample; and
g) Measuring the level of fluorescence
wherein the level of fluorescence corresponds to the concentration of the target oligonucleotide in the sample.
7 . The method of claim 6 , wherein the sample is contained in a microtiter plate.
8 . The method of claim 6 , where the presence or absence or an oligonucleotide in two or more samples is detected.
9 . The method of claim 8 , wherein the two or more samples are contained in different wells of a multiwell microtiter plate.
10 . The method of claim 6 , wherein the complementary oligonucleotide is conjugated to the fluorophore prior to adding to the sample.
11 . A method for detecting the presence or absence of two or more oligonucleotides in a sample, comprising the steps of:
a) Obtaining a sample;
b) Conjugating oligonucleotides that are complementary to two or more target oligonucleotides to different fluorphores;
c) Adding to the sample said complementary oligonucleotide-fluorophore conjugates to form a mixture;
d) Treating the mixture under conditions to allow binding of the complementary oligonucleotide-fluorophore conjugates to the two or more target oligonucleotides to form a duplex;
e) Detecting fluorescence of one of the complementary oligonucleotide-fluorophore conjugates being indicative of the presence of one of the target oligonucleotides; and
f) Repeating step e) for the remaining complementary oligonucleotide-fluorophore conjugate(s).
12 . A method for determining the concentration of two or more oligonucleotides in a sample, comprising the steps of:
a) Obtaining a sample;
b) Conjugating oligonucleotides that are complementary to two or more target oligonucleotides to different fluorphores;
c) Adding to the sample said complementary oligonucleotide-fluorophore conjugates to form a mixture;
d) Treating the mixture under conditions to allow binding of the complementary oligonucleotide-fluorophore conjugates to the two or more target oligonucleotides to form a duplex;
e) Detecting fluorescence of one of the complementary oligonucleotide-fluorophore conjugates being indicative of the presence of one of the target oligonucleotides;
f) Measuring the level of fluorescence; and
g) Repeating steps e) and f) for the remaining complementary oligonucleotide-fluorophore conjugate(s);
wherein the level of fluorescence corresponds to the concentration of the two or more oligonucleotides in the sample.